Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek
Oriola Corporation Stock Exchange Release 19 December 2024 at 2 p.m. EET Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek The integration in Oriola’s joint venture company Kronans Apotek has been more time-consuming than originally anticipated and the transition to one common ERP system has required more efforts than expected. Due to this, Kronans Apotek will record a goodwill impairment of approximately 373 million Swedish krona in its fourth quarter results. Oriola’s share of the impairment is approximately 187 million